NEWS

Estrogen

New Partnership Alert: MiraKind & genneve

MiraKind is committed to providing our community with the best tools possible to tackle challenges in the arena of women’s health. This is why MiraKind is partnering with genneve, a first-of-its-kind telehealth... Read More

More proof Hormone Replacement Therapy (HRT) is safe, effective, and beneficial for most women

When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing... Read More

Important Findings From Our Recently Published KRAS-Variant Study

A new study by MiraKind’s Founder, Dr. Joanne Weidhaas, in collaboration with her team at the University of California, Los Angeles and City of Hope, has been published in the scientific journal... Read More

New Research: “The KRAS-variant induces an epithelial-to-mesenchymal transition ‘EMT’ in normal breast epithelial cells”

As discussed in our previous Genetics series posts, the discovery of non-coding RNAs paved the way for changes in the Central Dogma and how we think about the flow of genetic information... Read More

New Research: How Inherited DNA -Based Mutations Impact Immunotherapy

The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we’ve spoken a lot... Read More

International Women’s Day Profile: Dr. Joanne Weidhaas

Here at MiraKind, we’re constantly inspired by the amazing women who surround us; whether it is scientists and doctors working on our research, or the strong and empowered women who are facing... Read More

Part 2 Q&A: Meet the MiraDx Research Team

“We’re pivoting from being focused on the disease to being focused on the patient and providing the tools to personalize each individual’s treatment.” –Mattias

Read More

Top 5 Reasons to Give a Charitable Donation this Holiday Season

This time of year, the malls and online stores are filled with shoppers, eager to purchase the perfect gift for friends and loved ones near and far. We may be biased, but... Read More

Part 1: Meet the UCLA Research Team Series

As an undergraduate volunteer in Dr. Weidhaas’ laboratory at UCLA, which focuses on the genetics behind cancer, and how it impacts biology—specifically microRNA genetic differences, such as MiraKind’s KRAS-variant, I have an... Read More

Breast Cancer Awareness Month

It’s Breast Cancer Awareness Month, so here at MiraKind, we’re taking a moment to think about the many ways in which breast cancer impacts our community.  Many of you may know that... Read More

Menopause & Myths about Hormone Replacement Therapy

For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN.  So what can we do about it? According to... Read More

What You Need to Know About Estrogen and the KRAS-variant

Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Weidhaas and her... Read More

DONATE

SUPPORT OUR RESEARCH

PARTICIPATE

HELP ADVANCE OUR RESEARCH